@usernamefrm0: no te olvides

idk
idk
Open In TikTok:
Region: US
Monday 19 October 2026 03:27:25 GMT
371
49
0
1

Music

Download

Comments

There are no more comments for this video.
To see more videos from user @usernamefrm0, please go to the Tikwm homepage.

Other Videos

DARK SPOT CONTROVERSY! 🔬 Why is hydroquinone still one of the most widely prescribed treatments for melasma when clinical research shows that topical tranexamic acid can deliver comparable results with potentially fewer side effects? Let's look at the evidence. THE CLINICAL TRIAL THAT CAUGHT MY ATTENTION In a randomized clinical trial involving 100 patients with melasma, researchers compared: 🔬 5% topical tranexamic acid 🔬 3% topical hydroquinone After 12 weeks, melasma severity improved by: 27% with tranexamic acid 26.7% with hydroquinone The difference in effectiveness was not statistically significant, but the tranexamic acid group reported fewer adverse effects and greater treatment satisfaction. Now consider the safety discussion. THE HYDROQUINONE COMPLICATION MORE PEOPLE SHOULD KNOW ABOUT Hydroquinone has been associated with exogenous ochronosis, a potentially persistent blue-black discoloration that can be extremely difficult to treat. A systematic review published in 2022 examined 126 reported cases of hydroquinone-associated ochronosis. Prolonged use and higher concentrations were frequently involved. This does NOT mean everyone using hydroquinone will develop ochronosis. Its true incidence is uncertain, and appropriate medical supervision matters. But it is a documented risk that deserves to be part of the conversation. WHAT MAKES TRANEXAMIC ACID DIFFERENT? Hydroquinone works primarily by inhibiting tyrosinase, an enzyme involved in melanin synthesis. Tranexamic acid works through a different pathway, influencing plasmin-related signaling involved in excess pigmentation. It is not an exfoliating acid. It doesn't need to peel away your skin to help improve discoloration. Clinical studies have demonstrated promising results for melasma, and published topical studies have not established an association between tranexamic acid alone and exogenous ochronosis. That doesn't mean zero risk. It means we should distinguish documented complications from hypothetical ones. MY FUNCTIONAL BEAUTY APPROACH Pigmentation is a biological process, not simply a stain sitting on the surface of your skin. UV exposure, visible light, inflammation and hormonal influences can all contribute. A thoughtful pigmentation routine should address the triggers while supporting the skin barrier. That means consistent sun protection, particularly tinted SPF containing iron oxides when visible light contributes to melasma, gentle skincare and appropriately selected pigment-targeting ingredients. I'm featuring OMIC's tranexamic acid serum because I believe this ingredient deserves more attention. The clinical trial above studied a specific 5% formulation, not OMIC's finished serum. Hydroquinone remains an effective prescription treatment, especially in certain combination therapies. But it should not be the only option consumers hear about. THE BEAUTY DOCTRINE VERDICT: Effective skincare isn't just about how quickly an ingredient fades a dark spot. Tolerability, long-term skin health and the risk of making pigmentation worse matter too. 📚 RESEARCH REFERENCES 1. Topical Tranexamic Acid versus Hydroquinone in the Treatment of Melasma, randomized clinical trial, 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6484568/ 2. Exogenous Ochronosis Associated with Hydroquinone: A Systematic Review, 2022.
https://pubmed.ncbi.nlm.nih.gov/34486734/ Save this before starting another pigmentation treatment. And tell me: have you ever been prescribed hydroquinone? #TranexamicAcid #Hydroquinone #Melasma #Hyperpigmentation #OMIC
DARK SPOT CONTROVERSY! 🔬 Why is hydroquinone still one of the most widely prescribed treatments for melasma when clinical research shows that topical tranexamic acid can deliver comparable results with potentially fewer side effects? Let's look at the evidence. THE CLINICAL TRIAL THAT CAUGHT MY ATTENTION In a randomized clinical trial involving 100 patients with melasma, researchers compared: 🔬 5% topical tranexamic acid 🔬 3% topical hydroquinone After 12 weeks, melasma severity improved by: 27% with tranexamic acid 26.7% with hydroquinone The difference in effectiveness was not statistically significant, but the tranexamic acid group reported fewer adverse effects and greater treatment satisfaction. Now consider the safety discussion. THE HYDROQUINONE COMPLICATION MORE PEOPLE SHOULD KNOW ABOUT Hydroquinone has been associated with exogenous ochronosis, a potentially persistent blue-black discoloration that can be extremely difficult to treat. A systematic review published in 2022 examined 126 reported cases of hydroquinone-associated ochronosis. Prolonged use and higher concentrations were frequently involved. This does NOT mean everyone using hydroquinone will develop ochronosis. Its true incidence is uncertain, and appropriate medical supervision matters. But it is a documented risk that deserves to be part of the conversation. WHAT MAKES TRANEXAMIC ACID DIFFERENT? Hydroquinone works primarily by inhibiting tyrosinase, an enzyme involved in melanin synthesis. Tranexamic acid works through a different pathway, influencing plasmin-related signaling involved in excess pigmentation. It is not an exfoliating acid. It doesn't need to peel away your skin to help improve discoloration. Clinical studies have demonstrated promising results for melasma, and published topical studies have not established an association between tranexamic acid alone and exogenous ochronosis. That doesn't mean zero risk. It means we should distinguish documented complications from hypothetical ones. MY FUNCTIONAL BEAUTY APPROACH Pigmentation is a biological process, not simply a stain sitting on the surface of your skin. UV exposure, visible light, inflammation and hormonal influences can all contribute. A thoughtful pigmentation routine should address the triggers while supporting the skin barrier. That means consistent sun protection, particularly tinted SPF containing iron oxides when visible light contributes to melasma, gentle skincare and appropriately selected pigment-targeting ingredients. I'm featuring OMIC's tranexamic acid serum because I believe this ingredient deserves more attention. The clinical trial above studied a specific 5% formulation, not OMIC's finished serum. Hydroquinone remains an effective prescription treatment, especially in certain combination therapies. But it should not be the only option consumers hear about. THE BEAUTY DOCTRINE VERDICT: Effective skincare isn't just about how quickly an ingredient fades a dark spot. Tolerability, long-term skin health and the risk of making pigmentation worse matter too. 📚 RESEARCH REFERENCES 1. Topical Tranexamic Acid versus Hydroquinone in the Treatment of Melasma, randomized clinical trial, 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6484568/ 2. Exogenous Ochronosis Associated with Hydroquinone: A Systematic Review, 2022.
https://pubmed.ncbi.nlm.nih.gov/34486734/ Save this before starting another pigmentation treatment. And tell me: have you ever been prescribed hydroquinone? #TranexamicAcid #Hydroquinone #Melasma #Hyperpigmentation #OMIC

About